Intramyocardial injection of autologous bone marrow
US7097832B1 · kind B1 · utility
13Cited by
6References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2000 |
| Grant date | Aug 29, 2006 |
| Priority date | — |
| Expiry date | Mar 30, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/1709
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of treating cardiac or myocardial conditions comprises the administration of an effective amount of autologous bone marrow. The bone marrow may optionally be stimulated and/or administered in combination with a pharmaceutical drug, protein, gene or other factor or therapy that may enhance bone marrow production of angiogenic growth factors and/or promote endothelial cell proliferation or migration or blood vessel formation.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.